Clinical Trials List
Protocol NumberITL-2001-CL-301
2024-05-01 - 2028-12-31
Phase III
Recruiting3
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Kon-Ping Lin 無
- 郭泠 無
- Yi-Chu Liao 無
- 廖若男 無
- Yo-Tsen Liu 無
- Shih-Hsien Sung 無
- Yi-Chun Lee 無
- 王維庭 無
- 黃偉銘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
765 participants
